Nitric oxide-mediated cutaneous microvascular function is not altered in young adults following mild-to-moderate SARS CoV-2 infection
Gabrielle A. Dillon, S. Tony Wolf, Lacy M. Alexander
Abstract
Healthy young adults who have had mild-to-moderate COVID-19 do not display alterations in nitric oxide-mediated cutaneous microvascular function. In addition, healthy young adults who have COVID-19 antibodies from the COVID-19 vaccinations do not display alterations in nitric oxide-mediated cutaneous microvascular function.
Topics & Concepts
Nitric oxideCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine2019-20 coronavirus outbreakVirologyInternal medicineDiseaseOutbreakInfectious disease (medical specialty)Thermoregulation and physiological responsesCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19